BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Business

  Transgenomic, Inc. Reports Second Quarter 2016 Financial Results

  August 15, 2016

   · 

  1 min read
• Business

  Syros Pharma Reports Second Quarter 2016 Financial Results And Provides Business Update

  August 15, 2016

   · 

  1 min read
• Pharm Country

  Teleflex Inc. Launches New Second-Generation 2.9 Mm Percuvance System – A Breakthrough Advance That Makes Percutaneous Approach To Laparoscopic Procedures Even Less Invasive

  August 15, 2016

   · 

  7 min read
• Drug Development

  Paratek Pharmaceuticals, Inc. Initiates Phase 3 Study Of Oral-Only Omadacycline In ABSSSI

  August 15, 2016

   · 

  5 min read
• Drug Development

  Results From Phase 1 Trials With Ligand’s LGD-6972 In Type 2 Diabetes Mellitus Published In Diabetes, Obesity And Metabolism

  August 15, 2016

   · 

  8 min read
• BioForest

  Translational Software Inc. Launches First FHIR-Based Pharmacogenomics API Allowing Healthcare Organizations And Software Developers To Quickly Scale And Accelerate Precision Medicine

  August 15, 2016

   · 

  3 min read
• Business

  Retrophin Appoints Neil Mcfarlane Chief Operating Officer

  August 15, 2016

   · 

  4 min read
• Business

  CohBar Announces Second Quarter 2016 Financial Results

  August 15, 2016

   · 

  1 min read
• Drug Development

  Tivorsan Pharmaceuticals, Inc. Granted FDA Orphan Drug Designation For Human Recombinant Biglycan In The Treatment Of Duchenne Muscular Dystrophy

  August 15, 2016

   · 

  3 min read
• Genetown

  PAREXEL International’s Head Of BioPharm Unit Named To The 2016 PharmaVOICE 100

  August 15, 2016

   · 

  3 min read